Evidence map›Paper›PMID 32368853›Full record

ArticleJournal of cellular and molecular medicine2020

An upstream open reading frame regulates vasculogenic mimicry of glioma via ZNRD1-AS1/miR-499a-5p/ELF1/EMI1 pathway.

Mo Wang, Chunqing Yang, Xiaobai Liu, Jian Zheng, Yixue Xue, Xuelei Ruan, Shuyuan Shen, Di Wang, Zhen Li, Heng Cai and 1 more

Expression of concernOpen access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It carries an expression of concern. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Combination of azithromycin and methylprednisolone alleviatesExperimental and therapeutic medicine · 2022
    Article
  11. The promising role and prognostic value of miR-198 in human diseases.American journal of translational research · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Mo WangDepartment of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, China.ORCID 0000-0002-1301-1011
Chunqing YangDepartment of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, China.
Xiaobai LiuDepartment of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, China.
Jian ZhengDepartment of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, China.
Yixue XueDepartment of Neurobiology, School of Life Sciences, China Medical University, Shenyang, China.
Xuelei RuanDepartment of Neurobiology, School of Life Sciences, China Medical University, Shenyang, China.
Shuyuan ShenDepartment of Neurobiology, School of Life Sciences, China Medical University, Shenyang, China.
Di WangDepartment of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, China.
Zhen LiDepartment of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, China.
Heng CaiDepartment of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, China.
Yunhui LiuDepartment of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, China.
Liaoning University · CNChina Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing evidence has suggested that gliomas can supply blood through vasculogenic mimicry. In this study, the expression and function of ZNRD1-AS1-144aa-uORF (144aa-uORF) and some non-coding RNAs in gliomas were assessed. Real-time quantitative PCR or Western blot was used to discover the expression of 144aa-uORF, ZNRD1-AS1, miR-499a-5p, ELF1 and EMI1 in gliomas. In addition, RIP and RNA pull-down assays were applied to explore the interrelationship between 144aa-uORF and ZNRD1-AS1. The role of the 144aa-uORF\ZNRD1-AS1\miR-499a-5p\ELF1\EMI1 axis in vasculogenic mimicry formation of gliomas was analysed. This study illustrates the reduced expression of the 144aa-uORF in glioma tissues and cells. Up-regulation of 144aa-uORF inhibits proliferation, migration, invasion and vasculogenic mimicry formation within glioma cells. The up-regulated 144aa-uORF can increase the degradation of ZNRD1-AS1 through the nonsense-mediated RNA decay (NMD) pathway. Knockdown of ZNRD1-AS1 inhibits vasculogenic mimicry in glioma cells by modulating miR-499a-5p. At the same time, miR-499a-5p is down-regulated and has a tumour-suppressive effect in gliomas. In addition, ZNRD1-AS1 serves as a competitive endogenous RNA (ceRNA) and regulates the expression of ELF1 by binding to miR-499a-5p. Notably, ELF1 binds to the promoter region of EMI1 and up-regulates EMI1 expression, while simultaneously promoting vasculogenic mimicry in glioma cells. This study suggests that the 144aa-uORF\ZNRD1-AS1\miR-499a-5p\ELF1\EMI1 axis takes key part in regulating the formation of vasculogenic mimicry in gliomas and may provide a potential target for glioma treatment.

Indexed as

Signal TransductionAnimalsBase SequenceBinding, CompetitiveBrain NeoplasmsCell Cycle ProteinsCell Line, TumorCell ProliferationDown-RegulationF-Box ProteinsGene Expression Regulation, NeoplasticGliomaHEK293 CellsHistocompatibility Antigens Class IHumansMice, NudeCell Cycle ProteinsELF1 protein, humanF-Box ProteinsFBXO5 protein, humanHistocompatibility Antigens Class IMicroRNAsMIRN499 microRNA, humanNuclear ProteinsTranscription FactorsZNRD1AS gene product, humancompetitive endogenous RNAgliomanonsense-mediated RNA decayupstream open reading framevasculogenic mimicryZNRD1-AS1

Identifiers

PMID32368853
PMCPMC7294115
OpenAlexW3023549264

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.